Results 211 to 220 of about 27,755 (279)

Emerging Role of Dual Glucagon-Like Peptide-1 (GLP-1)/Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Cardiovascular Prevention. [PDF]

Cureus
Contreras Figueroa N, Lopez Mendoza MJ, Ulloa A, Jiron Vindas J, Salazar Estrada MA, Valle Mena MJ.   +5 more
europepmc   +1 more source

The attenuated incretin effect is associated with glucose intolerance in patients with hepatitis B-related acute-on-chronic liver failure. [PDF]

Front Physiol
Li M, Hu H, Liu Y, Wu X, Zhang Y, Li Y, Yang F, Li Y, Lin S.   +8 more
europepmc   +1 more source

Early intervention with tirzepatide or semaglutide influences anti-atherosclerotic effects in ApoE knockout mice. [PDF]

Sci Rep
Dan K, Sanada J, Kimura T, Iwamoto Y, Sugisaki T, Iwamoto H, Fushimi Y, Nogami Y, Shirakiya Y, Shimoda M, Nakanishi S, Kaku K, Kaneto H.   +12 more
europepmc   +1 more source

Tirzepatide for weight and behavior management in a patient with Smith-Magenis syndrome. [PDF]

JCEM Case Rep
Liao XC, Huang T, Hong DS, Luo L.
europepmc   +1 more source

Endogenous GIP signaling is indispensable for DPP-4 inhibitor-mediated metabolic control in mice. [PDF]

J Diabetes Investig
Kubota-Okamoto S, Kubota S, Tsuchida H, Liu Y, Banno S, Imaizumi T, Fujisawa T, Takahashi Y, Kato T, Horikawa Y, Iizuka K, Murakami T, Fujiwara Y, Kuwata H, Yamazaki Y, Seino Y, Tsunekawa S, Yabe D.   +17 more
europepmc   +1 more source

The risk of digestive tract complications in patients with gastrointestinal lymphoma: a propensity score study. [PDF]

BMC Gastroenterol
Zhao Y, Zhang X, Zhou Y, Dai N, Li Y, He S.   +5 more
europepmc   +1 more source

Gips

, 2004
openaire   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression. [PDF]

Medicina (Kaunas)
Abenavoli L, Loricchio AG, Lopez I, Morano D, Ismaiel A, Dumitrascu DL, Luzza F.   +6 more
europepmc   +1 more source

Glucagon-Like Peptide-1 Receptor Agonists: Their Therapeutic Potential in Cystic Fibrosis. [PDF]

Adv Ther
Panou T, Gouveri E, Popovic DS, Papanas N.   +3 more
europepmc   +1 more source

The Role of Glucose-Dependent Insulinotropic Polypeptide (GIP) in Bone Metabolism. [PDF]

Int J Mol Sci
Lin A, Kitaura H, Ohori F, Marahleh A, Ma J, Fan Z, Narita K, Murakami K, Kanetaka H.   +8 more
europepmc   +1 more source